Настоящий прорыв. Первая персонализированная мРНК-вакцина против меланомы снижает риск рецидива и смерти на 42% NV Техно
Children and young adults who previously had differentiated thyroid cancer had increased risk for future malignancies compared with those who did not have thyroid cancer, researchers reported in Thyroid. “Second primary malignancies represent an important late outcome among children, adolescent and young adult…
Izalontamab Brengitecan (Iza-Bren) Doubles Median Progression-Free Survival in Patients with Previously-Treated EGFR-Mutated Non-Small Cell Lung Cancer Compared to Chemotherapy in the Phase 3 PANKU-Lung01 Study BioSpace
Genmab Shares Jump After Positive Cancer Study Results WSJ
ESMO26: Key data breathing new life into the lung cancer field Clinical Trials Arena
Roche’s divarasib cuts risk of death by 44% in lung cancer trial MedWatch
Ежегодно от рака легких вьетнамцы умирают более 21 000 человек. Vietnam.vn
ESMO 2026: NUBEQA® (darolutamide) Plus ADT and Radiation Therapy Reduces Risk of Metastasis or Death by 58% in Prostate Cancer Patients at High Risk of Recurrence BioSpace
Защита от скрытых угроз: жителям региона помогут вовремя выявить рак кишечника Официальный сайт Правительства и Губернатора Московской области
Theralase Provides Bladder Cancer Clinical Study Update Yahoo Finance
ESMO26: Combination therapies show promise in prostate cancer Clinical Trials Arena